Personalized Care
Personalized Care
批准号:
8898428
负责人:
TODD M HULGAN
金额:
$5.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2016-04-30
关键词:
AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAgreementApplications GrantsAreaAuthorshipAwardBiometryBiostatistics CoreCaringCenter for Translational Science ActivitiesCenters for Disease Control and Prevention (U.S.)Clinical InvestigatorClinical ResearchCommunitiesContinuity of Patient CareDataDatabasesDevelopmentEnvironmentFosteringFundingGoalsGrantGroup MeetingsHIVHealthHealth PolicyIndividualInformaticsInstitutesInstitutionInternationalInterventionJointsLaboratory ScientistsLeadershipMentorsMentorshipMethodsMissionOutcome MeasurePerformancePopulationProcessProtocols documentationPublic HealthPublicationsPublishingResearchResearch PersonnelResearch PriorityResourcesScheduleTennesseeTimeTranslational ResearchUnited States National Institutes of HealthWorkbiomedical informaticsclinical carecommunity planningdesignglobal healthhealth disparityimplementation researchimprovedinnovationinterestmeetingsmembernext generationpersonalized careprogramsworking group
中文摘要
SWG -项目总结
田纳西州CFAR(TN-CFAR)科学工作组(SWG)将由以下成员组成:
在科学发现、临床护理、公共卫生、生物统计学、信息学和社区方面的专业知识
参与,并将利用伙伴机构的优势。最初的工作组-艾滋病毒护理的连续性
和个性化艾滋病毒护理-被确定为高度优先领域,利用这些优势,
我们的目标是利用当地资源,并使我们的CFAR在实地产生最大的影响。这些SWG具有协同作用,
目标是改善人口和个人层面的艾滋病毒护理,并将推动研究和实施
战略,以促进TN-CFAR使命提供艾滋病毒/艾滋病研究领导在我们的机构,
指导下一代艾滋病毒研究人员,并最终减轻艾滋病毒/艾滋病的负担。具体目标
两个SWG将(1)连接临床研究者、实验室科学家、公共卫生从业者,
社区利益相关者;以及(2)培养跨机构和跨学科的礼宾团队,
实施和完成合作研究,解决每个领域的关键问题。这些目标将是
通过行政核心监督的每个SWG共同的流程实现,以及
针对每个工作组的若干倡议和次级目标。开发下一代艾滋病毒/艾滋病
调查人员,两个SWG将实施专门设计的流程,以吸引新的和初级的
调查人员将提供一个促进有效指导的环境,并将确保每个人
新的/初级调查员有一个特定的导师。这些工作组将高度数据驱动,与
行政核心和生物统计学和生物医学信息学核心,以开发REDCap数据库,
收集和传播关于SWG性能的实时数据。在最重要的结果测量中,
将是:1)具有跨机构,跨学科作者的高影响力出版物; 2)新的赠款
跨机构和跨学科的提交和授予。收集的其他数据,
评价将包括所有三个伙伴机构和社区利益攸关方的参与程度,
新的和初级调查员,以及为初级调查员确定的导师。每个SWG都包括一个创新的
由一名接受指导的初级调查员领导的概念项目将在TN-CFAR的第一年启动。
英文摘要
SWG - PROJECT SUMMARY
The Tennessee CFAR (TN-CFAR) Scientific Working Groups (SWGs) will be comprised of members with
expertise in scientific discovery, clinical care, public health, biostatistics, informatics, and community
engagement, and will leverage strengths of the partner institutions. The initial SWGs—Continuum of HIV Care
and Personalized HIV Care—were identified as high-priority areas that take advantage of these strengths and
local resources, and to allow our CFAR to have the greatest impact on the field. These SWGs have synergistic
goals to improve HIV care on the population and individual level, and will drive research and implementation
strategies to contribute to the TN-CFAR mission to provide HIV/AIDS research leadership at our institutions,
mentor the next generation of HIV researchers, and ultimately reduce the burden of HIV/AIDS. Specific Aims of
both SWGs will be to (1) connect clinical investigators, laboratory scientists, public health practitioners, and
community stakeholders; and (2) nurture trans-institutional and trans-disciplinary protocol teams that
implement and complete collaborative research addressing critical questions in each area. These Aims will be
achieved through processes common to each SWG that will be overseen by the Administrative Core, and
several initiatives and Sub-aims specific to each SWG. To develop the next generation of HIV/AIDS
investigators, both SWGs will implement processes specifically designed to attract new and junior
investigators, will provide an environment that fosters effective mentorship, and will assure that each
new/junior investigator has a specific mentor. These SWGs will be highly data-driven, working with the
Administrative Core and the Biostatistics and Biomedical Informatics Core to develop REDCap databases to
collect and disseminate real-time data on SWG performance. Among the most important outcome measures
will be: 1) high impact publications with trans-institutional, trans-disciplinary authorship; and 2) new grant
submissions and awards that are trans-institutional and trans-disciplinary. Additional data collected and
evaluated will include extent of engagement from all three partner institutions and community stakeholders,
new and junior investigators, and mentors identified for junior investigators. Each SWG includes an innovative
concept project led by a mentored junior investigator to be initiated in Year 1 of the TN-CFAR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the Contribution of Mitochondrial DNA to Viral Infectious Diseases, Type 2 Diabetes, and their Interactions
-
批准号:10589249
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8294542
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8845250
-
项目类别:
-
资助金额:$46.29万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8458599
-
项目类别:
-
资助金额:$63.8万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8896116
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8658731
-
项目类别:
-
资助金额:$52.17万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Iron and Mitochondrial Genomics in Neuro-inflammation and HAND: A CHARTER Study
-
批准号:8210312
-
项目类别:
-
资助金额:$69.86万
-
财政年份:2011
-
负责人:TODD M HULGAN
-
依托单位:
Mitochondrial Genomics and Effects of Cocaine on T cells during HIV-Infection
-
批准号:8112582
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2010
-
负责人:TODD M HULGAN
-
依托单位:
Mitochondrial Genomics and Effects of Cocaine on T cells during HIV-Infection
-
批准号:7931761
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2010
-
负责人:TODD M HULGAN
-
依托单位:
Mitochondrial Genomics and Peripheral Neuropathy during HIV Therapy
-
批准号:7284699
-
项目类别:
-
资助金额:$26.83万
-
财政年份:2007
-
负责人:TODD M HULGAN
-
依托单位:
Mitochondrial Genomics and Peripheral Neuropathy during HIV Therapy
-
批准号:7383762
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2007
-
负责人:TODD M HULGAN
-
依托单位:
LIPOATROPHY AND NEUROPATHY COHORT (LINC) STUDY
-
批准号:7605644
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2006
-
负责人:TODD M HULGAN
-
依托单位:
LIPOATROPHY AND NEUROPATHY COHORT (LINC) STUDY
-
批准号:7731468
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2006
-
负责人:TODD M HULGAN
-
依托单位:
Oxidant Stress and Antioxidants during HIV Therapy
-
批准号:6946518
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2004
-
负责人:TODD M HULGAN
-
依托单位:
Oxidant Stress and Antioxidants during HIV Therapy
-
批准号:7070633
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2004
-
负责人:TODD M HULGAN
-
依托单位:
Oxidant Stress and Antioxidants during HIV Therapy
-
批准号:6844402
-
项目类别:
-
资助金额:$11.8万
-
财政年份:2004
-
负责人:TODD M HULGAN
-
依托单位:
海外基金